Trinity Biotech PLC (TRIB)
1.69
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
1.69
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Price: 1.69 for Nov. 4, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 01, 2024 | 1.72 | 1.76 | 1.67 | 1.69 | 65228.00 |
Oct 31, 2024 | 1.85 | 1.885 | 1.72 | 1.76 | 56174.00 |
Oct 30, 2024 | 2.00 | 2.05 | 1.84 | 1.87 | 120842.0 |
Oct 29, 2024 | 2.18 | 2.18 | 1.99 | 2.02 | 179071.0 |
Oct 28, 2024 | 1.98 | 2.21 | 1.97 | 2.20 | 364950.0 |
Oct 25, 2024 | 1.81 | 2.11 | 1.79 | 1.93 | 862198.0 |
Oct 24, 2024 | 1.56 | 2.05 | 1.55 | 1.83 | 827585.0 |
Oct 23, 2024 | 1.61 | 1.61 | 1.52 | 1.55 | 65882.00 |
Oct 22, 2024 | 1.63 | 1.63 | 1.52 | 1.55 | 95871.00 |
Oct 21, 2024 | 1.71 | 1.729 | 1.61 | 1.63 | 81502.00 |
Oct 18, 2024 | 1.77 | 1.783 | 1.67 | 1.71 | 57782.00 |
Oct 17, 2024 | 1.80 | 1.83 | 1.72 | 1.755 | 158436.0 |
Oct 16, 2024 | 1.69 | 1.82 | 1.652 | 1.78 | 83205.00 |
Oct 15, 2024 | 1.66 | 1.70 | 1.610 | 1.682 | 85101.00 |
Oct 14, 2024 | 2.02 | 2.02 | 1.52 | 1.72 | 314600.0 |
Oct 11, 2024 | 1.82 | 2.058 | 1.79 | 2.00 | 454681.0 |
Oct 10, 2024 | 1.77 | 1.83 | 1.66 | 1.81 | 219609.0 |
Oct 09, 2024 | 1.63 | 1.80 | 1.63 | 1.73 | 383636.0 |
Oct 08, 2024 | 1.41 | 1.61 | 1.38 | 1.555 | 338218.0 |
Oct 07, 2024 | 1.20 | 1.38 | 1.20 | 1.36 | 166222.0 |
Oct 04, 2024 | 1.18 | 1.20 | 1.12 | 1.20 | 26328.00 |
Oct 03, 2024 | 1.19 | 1.19 | 1.15 | 1.16 | 51783.00 |
Oct 02, 2024 | 1.11 | 1.19 | 1.104 | 1.18 | 85467.00 |
Oct 01, 2024 | 1.09 | 1.19 | 1.085 | 1.17 | 94341.00 |
Sep 30, 2024 | 1.13 | 1.13 | 1.051 | 1.10 | 75003.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.09
Minimum
Sep 27 2024
33.20
Maximum
Feb 16 2021
7.691
Average
5.75
Median
Feb 10 2020
Price Benchmarks
Amarin Corp PLC | 0.6082 |
DBV Technologies SA | 0.7831 |
Ascendis Pharma AS | 125.66 |
Cellectis SA | 1.77 |
Adaptimmune Therapeutics PLC | 0.8246 |
Price Related Metrics
PS Ratio | 0.2962 |
Earnings Yield | -159.5% |
Market Cap | 16.00M |